Ex-Pandion execs, Harvard’s Springer team up for AI-guided immunology play Seismic

With the backing of a VC syndicate that has invested $101 million in series A cash, Seismic’s team of Pandion veterans hopes to use the start-up’s machine learning-guided platform to develop therapies that target the adaptive immune system.

The round’s leader, Lightspeed Venture Partners, joined seed investors Timothy Springer and Polaris Partners in funding Seismic Therapeutic Inc. Springer, a co-founder of the start-up, is a Harvard Medical School professor and a serial entrepreneur...